Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(19)
Published: April 30, 2024
Snakebite
envenoming
is
a
neglected
tropical
disease
that
causes
substantial
mortality
and
morbidity
globally.
The
venom
of
African
spitting
cobras
often
permanent
injury
via
tissue-destructive
dermonecrosis
at
the
bite
site,
which
ineffectively
treated
by
current
antivenoms.
To
address
this
therapeutic
gap,
we
identified
etiological
toxins
in
Naja
nigricollis
responsible
for
causing
local
dermonecrosis.
While
cytotoxic
three-finger
were
primarily
cobra
cytotoxicity
cultured
keratinocytes,
their
potentiation
phospholipases
A
2
was
essential
to
cause
vivo.
This
evidence
probable
toxin
synergism
suggests
single
toxin-family
inhibiting
drug
could
prevent
envenoming.
We
show
injection
with
repurposed
phospholipase
-inhibiting
varespladib
significantly
prevents
tissue
damage
caused
several
venoms
murine
models
Our
findings
therefore
provide
strategy
may
effectively
life-changing
snakebite
rural
Africa.
PLoS neglected tropical diseases,
Journal Year:
2021,
Volume and Issue:
15(3), P. e0009247 - e0009247
Published: March 25, 2021
Background
Snakebite
in
India
results
over
58,000
fatalities
and
a
vast
number
of
morbidities
annually.
The
majority
these
clinically
severe
envenomings
are
attributed
to
Russell’s
viper
(
Daboia
russelii
),
which
has
near
pan-India
distribution.
Unfortunately,
despite
its
medical
significance,
the
influence
biogeography
on
composition
potency
venom
from
disparate
D
.
populations,
repercussions
variation
neutralisation
efficacy
marketed
Indian
antivenoms,
remain
elusive.
Methods
Here,
we
employ
an
integrative
approach
comprising
proteomic
characterisation,
biochemical
analyses,
pharmacological
assessment,
toxicity
profiling
elucidate
varying
ecology
environment
pan-Indian
populations
We
then
conducted
vitro
recognition
experiments
vivo
assays
evaluate
commercial
antivenoms
against
geographically
populations.
Findings
reveal
significant
intraspecific
composition,
activities
potencies
venoms
sourced
five
distinct
biogeographic
zones
across
India.
Contrary
our
understanding
consequences
effectiveness
snakebite
therapy,
antivenom
exhibited
surprisingly
similar
investigated
with
exception
low
preclinical
semi-arid
population
northern
However,
ability
counter
morbid
effects
envenoming
remains
be
evaluated.
Conclusion
concerning
lack
north
,
as
well
two
other
‘big
four’
snake
species
nearby
locations,
underscores
pressing
need
develop
effective
improved
high
burden
locales.
Toxins,
Journal Year:
2021,
Volume and Issue:
13(6), P. 427 - 427
Published: June 17, 2021
Fine-tuned
by
millions
of
years
evolution,
snake
venoms
have
frightened
but
also
fascinated
humanity
and
nowadays
they
constitute
potential
resources
for
drug
development,
therapeutics
antivenoms.
The
continuous
progress
mass
spectrometry
techniques
latest
advances
in
proteomics
workflows
enabled
toxinologists
to
decipher
modern
omics
technologies,
so-called
‘venomics’.
A
tremendous
upsurge
reporting
on
venom
proteomes
could
be
observed.
Within
this
review
we
focus
the
highly
venomous
widely
distributed
subfamily
Viperinae
(Serpentes:
Viperidae).
detailed
public
literature
database
search
was
performed
(2003–2020)
extensively
reviewed
all
compositional
studies
Old-World
Vipers.
In
total,
54
resulted
89
proteomes.
are
dominated
four
major,
secondary,
six
minor
several
rare
toxin
families
peptides,
respectively.
multitude
different
venomics
approaches
complicates
comparison
composition
datasets
therefore
differentiated
between
non-quantitative
three
groups
quantitative
workflows.
resulting
direct
comparisons
within
these
show
remarkable
differences
intra-
interspecies
level
across
genera
with
a
regional
differences.
summary,
present
compilation
is
first
comprehensive
up-to-date
differentiating
analytical
methods
Frontiers in Pharmacology,
Journal Year:
2022,
Volume and Issue:
12
Published: Jan. 14, 2022
Understanding
snake
venom
proteomes
is
becoming
increasingly
important
to
understand
biology,
evolution
and
especially
clinical
effects
of
venoms
approaches
antivenom
development.
To
explore
the
current
state
proteomics
transcriptomics
we
investigated
proteomic
methods,
associations
between
methodological
biological
variability
diversity
abundance
protein
families.
We
reviewed
available
studies
on
from
September
2017
April
2021.
This
included
81
characterising
79
species,
providing
data
relative
toxin
for
70
species
(number
different
toxins)
37
species.
Methodologies
utilised
in
these
were
summarised
compared.
Several
comparative
showed
that
preliminary
decomplexation
crude
by
chromatography
leads
increased
identification,
as
does
use
transcriptomics.
Combining
strategies
venomic
appears
maximize
proteome
coverage.
48%
used
RP-HPLC
→1D
SDS-PAGE
→
in-gel
trypsin
digestion
ESI
-LC-MS/MS
pathway.
Protein
quantification
MS1-based
spectral
intensity
was
twice
commonly
MS2-based
counting
(33–15
studies).
Total
25–225
toxins/species,
with
a
median
48.
The
mean
four
dominant
families
elapids;
3FTx–52%,
PLA
2
–27%,
SVMP–2.8%,
SVSP–0.1%,
vipers:
3FTx–0.5%,
–24%,
SVMP–27%,
SVSP–12%.
Viper
compositionally
more
complex
than
elapid
terms
number
making
up
most
venom,
contrast,
made
fewer,
but
diverse,
No
relationship
observed
abundance.
For
equivalent
comparisons
be
studies,
there
need
clarify
differences
acceptance
standardised
classification,
nomenclature
reporting
procedure.
Correctly
measuring
comparing
essential
understanding
biological,
evolutionary
implications
composition.
Toxins,
Journal Year:
2022,
Volume and Issue:
14(4), P. 247 - 247
Published: March 30, 2022
Venomic
research,
powered
by
techniques
adapted
from
proteomics,
transcriptomics,
and
genomics,
seeks
to
unravel
the
diversity
complexity
of
venom
through
which
knowledge
can
be
applied
in
treatment
envenoming,
biodiscovery,
conservation.
Snake
proteomics
is
most
extensively
studied,
but
methods
varied
widely,
creating
a
massive
amount
information
complicates
data
comparison
interpretation.
Advancement
mass
spectrometry
technology,
accompanied
growing
databases
sophisticated
bioinformatic
tools,
has
overcome
earlier
limitations
protein
identification.
The
progress,
however,
remains
challenged
limited
accessibility
samples,
non-standardized
quantitative
methods,
biased
interpretation
-omic
data.
Next-generation
sequencing
(NGS)
technologies
enable
high-throughput
venom-gland
transcriptomics
complementing
providing
deeper
insights
into
structural
diversity,
differential
expression,
regulation
functional
interaction
toxin
genes.
tissue
sampling
is,
difficult
due
strict
regulations
on
wildlife
use
transfer
biological
materials
some
countries.
Limited
resources
for
funding
are
among
other
pertinent
issues
that
impede
progress
venomics,
particularly
less
developed
regions
neglected
species.
Genuine
collaboration
between
international
researchers,
recognition
regional
experts
global
organizations
(e.g.,
WHO),
improved
distribution
research
support,
should
embraced.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Aug. 4, 2022
Bites
by
elapid
snakes
(e.g.
cobras)
can
result
in
life-threatening
paralysis
caused
venom
neurotoxins
blocking
neuromuscular
nicotinic
acetylcholine
receptors.
Here,
we
determine
the
cryo-EM
structure
of
muscle-type
Torpedo
receptor
complex
with
ScNtx,
a
recombinant
short-chain
α-neurotoxin.
ScNtx
is
pinched
between
loop
C
on
principal
subunit
and
unique
hairpin
F
complementary
subunit,
thereby
access
to
neurotransmitter
binding
site.
adopts
mode
that
tilted
toward
forming
wider
network
interactions
than
those
seen
long-chain
α-Bungarotoxin
complex.
Certain
mutations
at
toxin-receptor
interface
eliminate
inhibition
neuronal
α7
nAChRs,
but
not
human
These
observations
explain
why
binds
more
tightly
receptors
Together,
these
data
offer
framework
for
understanding
subtype-specific
actions
α-neurotoxins
inspire
strategies
design
new
snake
antivenoms.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Feb. 8, 2023
Abstract
Snakebite
envenoming
continues
to
claim
many
lives
across
the
globe,
necessitating
development
of
improved
therapies.
To
this
end,
broadly-neutralizing
human
monoclonal
antibodies
may
possess
advantages
over
current
plasma-derived
antivenoms
by
offering
superior
safety
and
high
neutralization
capacity.
Here,
we
report
establishment
a
pipeline
based
on
phage
display
technology
for
discovery
optimization
affinity
antibodies.
This
approach
yielded
recombinant
antibody
with
capacities
in
vitro
vivo
against
different
long-chain
α-neurotoxins
from
elapid
snakes.
prevents
lethality
induced
Naja
kaouthia
whole
venom
at
an
unprecedented
low
molar
ratio
one
per
toxin
prolongs
survival
mice
injected
Dendroaspis
polylepis
or
Ophiophagus
hannah
venoms.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(3), P. 2919 - 2919
Published: Feb. 2, 2023
Snake
venoms
as
tools
for
hunting
are
primarily
aimed
at
the
most
vital
systems
of
prey,
especially
nervous
and
circulatory
systems.
In
general,
snakes
Elapidae
family
produce
neurotoxic
comprising
toxins
targeting
system,
while
Viperidae
rear-fanged
hemotoxic
directed
mainly
on
blood
coagulation.
However,
it
is
not
all
so
clear.
Some
bites
by
viperids
results
in
signs
now
known
that
do
contain
components.
For
example,
viperid
phospholipases
A2
may
manifest
pre-
or/and
postsynaptic
activity
be
involved
pain
analgesia.
There
other
neurotoxins
belonging
to
diverse
families
ranging
from
large
multi-subunit
proteins
(e.g.,
C-type
lectin-like
proteins)
short
peptide
waglerins
azemiopsin),
which
found
venoms.
Other
include
baptides,
crotamine,
cysteine-rich
secretory
proteins,
Kunitz-type
protease
inhibitors,
sarafotoxins
three-finger
toxins.
these
exhibit
activity,
others
affect
functioning
voltage-dependent
ion
channels.
This
review
represents
first
attempt
systematize
data
“non-neurotoxic”
snake
venom.
The
structural
functional
characteristic
affecting
targets
system
considered.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Dec. 14, 2023
Morbidity
from
snakebite
envenoming
affects
approximately
400,000
people
annually.
Tissue
damage
at
the
bite-site
often
leaves
victims
with
catastrophic
life-long
injuries
and
is
largely
untreatable
by
current
antivenoms.
Repurposed
small
molecule
drugs
that
inhibit
specific
snake
venom
toxins
show
considerable
promise
for
tackling
this
neglected
tropical
disease.
Using
human
skin
cell
assays
as
an
initial
model
snakebite-induced
dermonecrosis,
we
2,3-dimercapto-1-propanesulfonic
acid
(DMPS),
marimastat,
varespladib,
alone
or
in
combination,
cytotoxicity
of
a
broad
range
medically
important
venoms.
Thereafter,
using
preclinical
mouse
models
demonstrate
dual
therapeutic
combinations
DMPS
marimastat
varespladib
significantly
dermonecrotic
activity
geographically
distinct
venoms,
even
when
drug
are
delivered
one
hour
after
envenoming.
These
findings
strongly
support
future
translation
repurposed
broad-spectrum
therapeutics
preventing
morbidity
caused
snakebite.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Jan. 16, 2023
Abstract
Venom
is
a
complex
trait
with
substantial
inter-
and
intraspecific
variability
resulting
from
strong
selective
pressures
acting
on
the
expression
of
many
toxic
proteins.
However,
understanding
processes
underlying
toxin
dynamics
that
determine
venom
phenotype
remains
unresolved.
By
interspecific
comparisons
we
reveal
in
sea
anemones
evolves
rapidly
each
species
different
family
dictates
by
massive
gene
duplication
events.
In-depth
analysis
anemone,
Nematostella
vectensis
,
revealed
striking
variation
dominant
(
Nv1
)
diploid
copy
number
across
populations
(1-24
copies)
independent
expansion/contraction
events,
which
generate
distinct
haplotypes.
correlates
at
both
transcript
protein
levels
one
population
having
near-complete
loss
production.
Finally,
establish
hypothesis
incorporates
observations
other
venomous
lineages
animals
have
convergently
evolved
similar
strategy
shaping
their
venom.